OncoZenge AB (OSTO:ONCOZ) Price-to-Tangible-Book : 4.42 (As of Jun. 08, 2024)

View and export this data going back to 2021. Start your Free Trial

What is OncoZenge AB Price-to-Tangible-Book?

As of today (2024-06-08), OncoZenge AB's share price is kr3.55. OncoZenge AB's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was kr0.80. Hence, OncoZenge AB's Price to Tangible Book Ratio of today is 4.42.

The historical rank and industry rank for OncoZenge AB's Price-to-Tangible-Book or its related term are showing as below:

OSTO:ONCOZ' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.03 Med: 2.37 Max: 4.51
Current: 4.44

During the past 4 years, OncoZenge AB's highest Price to Tangible Book Ratio was 4.51. The lowest was 1.03. And the median was 2.37.

OSTO:ONCOZ's Price-to-Tangible-Book is ranked worse than
68.56% of 1218 companies
in the Biotechnology industry
Industry Median: 2.79 vs OSTO:ONCOZ: 4.44

A closely related ratio is called PB Ratio. As of today, OncoZenge AB's share price is kr3.55. OncoZenge AB's Book Value per Sharefor the quarter that ended in Mar. 2024 was kr1.39. Hence, OncoZenge AB's P/B Ratio of today is 2.56.

OncoZenge AB Price-to-Tangible-Book Historical Data

The historical data trend for OncoZenge AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoZenge AB Price-to-Tangible-Book Chart

OncoZenge AB Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

2.69

2.37

3.07

OncoZenge AB Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial									3.76	4.13	2.24	3.07	4.23

Competitive Comparison of OncoZenge AB's Price-to-Tangible-Book

For the Biotechnology subindustry, OncoZenge AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoZenge AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoZenge AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where OncoZenge AB's Price-to-Tangible-Book falls into.

OncoZenge AB Price-to-Tangible-Book Calculation

OncoZenge AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	3.55	/	0.804
	=	4.42

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

OncoZenge AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of OncoZenge AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

OncoZenge AB (OSTO:ONCOZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoZenge AB (OSTO:ONCOZ) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

8LY:Germany

Address

Gustavslundsvagen 34, Bromma, SWE, 167 51

Website

https://www.oncozenge.com

OncoZenge AB is a pharmaceutical company that is developing a new treatment for effective pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. In phase 2 patient studies, the company's product candidate BupiZenge displayed pain relief compared with standard therapy. It focuses on implementing a phase development program as a basis for regulatory approvals and product launches.

OncoZenge AB (OSTO:ONCOZ) Headlines

No Headlines